Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 63 entries
View as:

A Clinical Study in Healthy Subjects Which Aims to Investigate the Safety, the Tolerability and the Effects of GRT0151Y and How the Compound is Taken up and Excreted From the Body

Phase: N/A Priority: Normal
NCT ID: NCT03761407 Org: User:
Start: 12/30/04 End: 07/26/05 Due: 07/26/06

Efficacy and Safety of RTX-GRT7039 in Adult Subjects With Knee Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT05248386 Org: User:
Start: 08/26/22 End: 11/18/24 Due: 11/18/25

Intravenous Tapentadol in Post-Bunionectomy Pain

Phase: N/A Priority: Normal
NCT ID: NCT01435577 Org: User:
Start: 09/30/11 End: 02/29/12 Due: 02/28/13

Intra-articular Lopain (MTX-071) Phase I/IIa Study in Chronic Osteoarthritic Knee Joint Pain

Phase: N/A Priority: Normal
NCT ID: NCT02566564 Org: User:
Start: 04/30/16 End: 06/30/17 Due: 06/30/18

Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking WHO Step III Analgesics But Showing a Lack of Tolerability.

Phase: N/A Priority: Normal
NCT ID: NCT00982280 Org: User:
Start: 09/30/09 End: 08/31/10 Due: 08/31/11

A Study in Healthy Male Volunteers to Investigate the Safety and Tolerability of a Single Dose of Neosaxitoxin Alone and in Combination With Bupivacaine (With and Without Epinephrine) for Brachial Plexus Blockade

Phase: N/A Priority: Normal
NCT ID: NCT03399435 Org: User:
Start: 01/30/18 End: 09/21/18 Due: 09/21/19

Comparison of Increasing Doses of Tapentadol Versus a Combination of Tapentadol and Pregabalin

Phase: N/A Priority: Normal
NCT ID: NCT01352741 Org: User:
Start: 03/31/11 End: 01/31/12 Due: 01/31/13

Tapentadol in Chronic Malignant Tumour Related Pain

Phase: N/A Priority: Normal
NCT ID: NCT01264887 Org: User:
Start: 03/31/11 End: 05/31/14 Due: 05/31/15

Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking WHO Step III Analgesics But Showing a Lack of Tolerability

Phase: N/A Priority: Normal
NCT ID: NCT00986258 Org: User:
Start: 10/30/09 End: 01/31/11 Due: 01/31/12

A Comparison of How Likely it is That Different Tablets of Oxycodone Will be Broken up and Snorted by Adults Who Sometimes Take Drugs for Pleasure

Phase: N/A Priority: Normal
NCT ID: NCT03765346 Org: User:
Start: 07/24/18 End: 11/05/18 Due: 11/05/19

A Clinical Study in Healthy Women Which Aims to Explore the Intestinal Uptake of Two Different Tablets of GRTA9906 Into the Body and the Effect of Food on it

Phase: N/A Priority: Normal
NCT ID: NCT03765801 Org: User:
Start: 10/22/03 End: 12/11/03 Due: 12/11/04

Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking Either WHO Step I or Step II Analgesics or no Regular Analgesic

Phase: N/A Priority: Normal
NCT ID: NCT00983073 Org: User:
Start: 09/30/09 End: 09/30/10 Due: 09/30/11

A Clinical Study to Compare MAR-CUTIS With Dermabond Advanced

Phase: N/A Priority: Normal
NCT ID: NCT03688880 Org: User:
Start: 10/30/18 End: 09/04/19 Due: 09/04/20

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Phase: N/A Priority: Normal
NCT ID: NCT01838616 Org: User:
Start: 04/30/13 End: 01/31/14 Due: 01/31/15

Single Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID 297307)

Phase: N/A Priority: Normal
NCT ID: NCT00469404 Org: User:
Start: 05/31/07 End: 11/30/07 Due: 11/30/08

Effect of a Multiple-dose Oral Administration of CG5503 PR on the Electrical Activity of the Heart in 48 Healthy Men and Women

Phase: N/A Priority: Normal
NCT ID: NCT03951402 Org: User:
Start: 03/31/03 End: 08/31/03 Due: 08/31/04

A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine

Phase: N/A Priority: Normal
NCT ID: NCT00505414 Org: User:
Start: 06/30/07 End: 05/31/09 Due: 05/31/10

Clinical Study in Healthy Men to Investigate the Uptake of Buprenorphine and Its Elimination From the Body After Dermal Application as Patches for 96 Hours and for 72 Hours

Phase: N/A Priority: Normal
NCT ID: NCT03770234 Org: User:
Start: 04/05/04 End: 05/26/04 Due: 05/26/05

Pharmacokinetic Non-interaction Study With a Fixed-dose Combination Tablet With Tramadol and Diclofenac

Phase: N/A Priority: Normal
NCT ID: NCT03766984 Org: User:
Start: 06/07/15 End: 06/23/15 Due: 06/23/16

A Study to Look at Tapentadol Tablets in Children and Adolescents in Pain

Phase: N/A Priority: Normal
NCT ID: NCT02151682 Org: User:
Start: 04/29/15 End: 10/15/18 Due: 10/15/19

Characterization of the Pharmacokinetics of a Vaginal Ring With 2.0 g Progesterone in Post-menopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT03737656 Org: User:
Start: 11/01/18 End: 05/09/19 Due: 05/09/20

A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of a New and a Marketed Tablet Formulation Under Fasted and Fed Conditions in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT03137017 Org: User:
Start: 09/30/17 End: 11/30/17 Due: 11/30/18

Efficacy and Safety of Intravenous Neridronic Acid in CRPS

Phase: N/A Priority: Normal
NCT ID: NCT03530345 Org: User:
Start: 05/30/18 End: 07/31/19 Due: 07/31/20

A Study With Lido-Patch and Placebo Plaster in Patients Suffering From Postherpetic Neuralgia (PHN)

Phase: N/A Priority: Normal
NCT ID: NCT03745404 Org: User:
Start: 04/29/03 End: 06/30/04 Due: 06/30/05

Investigation How CG5503 is Taken up and Excreted From the Body After 2 Minutes Intravenous Infusion With and Without Oral Co-administration of Charcoal

Phase: N/A Priority: Normal
NCT ID: NCT03951987 Org: User:
Start: 02/29/04 End: 04/30/04 Due: 04/30/05